SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-21-006807
Filing Date
2021-03-25
Accepted
2021-03-25 16:15:42
Documents
81
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 1121130
2 ex4-6.htm EX-4.6 7832
3 ex10-15.htm EX-10.15 30651
4 ex21-1.htm EX-21.1 3706
5 ex23-1.htm EX-23.1 4076
6 ex31-1.htm EX-31.1 11304
7 ex31-2.htm EX-31.2 8093
8 ex32-1.htm EX-32.1 9106
9 form10-k_001.jpg GRAPHIC 77753
  Complete submission text file 0001493152-21-006807.txt   4755668

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE FILE pcsa-20201231.xml EX-101.INS 519101
11 XBRL SCHEMA FILE pcsa-20201231.xsd EX-101.SCH 62681
12 XBRL CALCULATION FILE pcsa-20201231_cal.xml EX-101.CAL 70735
13 XBRL DEFINITION FILE pcsa-20201231_def.xml EX-101.DEF 225456
14 XBRL LABEL FILE pcsa-20201231_lab.xml EX-101.LAB 425299
15 XBRL PRESENTATION FILE pcsa-20201231_pre.xml EX-101.PRE 341233
Mailing Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076
Business Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076 443-776-3133
Processa Pharmaceuticals, Inc. (Filer) CIK: 0001533743 (see all company filings)

IRS No.: 451539785 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39531 | Film No.: 21772547
SIC: 2834 Pharmaceutical Preparations